Executive Team
Anthony H. Cincotta, PhD
President, Chief Science Officer & Founder
Dr. Cincotta is the founder and is responsible for overseeing all research and development.
He has over 23 successful years in clinical research, development and is recognized as on of the worlds leading authorities on Metabolic Syndrome and Neuroendrocrine Resetting Therapy.
Bindu Chamarthi, MD
Medical Director
Dr. Chamarthi earned her MD from Karnatak Medical College
Dr. Chamarthi oversees all Clinical Operations for VeroScience.
Michael Ezrokhi, PhD
Lead Scientist Molecular Biology
Dr. Ezrokhi earned his PhD from Brown University
Dr. Ezrokhi primarily works in the field of Molecular Biology and oversees all research and development in this area.
Shuqin Luo, PhD, MD
Lead Scientist Neuroscience
Dr. Luo earned her PhD from the University of Toronto
Dr. Luo primarily works in the field of Neuroscience and oversees all research and development in this area.
Yahong Zhang, PhD
Lead Scientist Neuroscience
Dr. Zhang earned her PhD degree in neuropharmacology from Loyola University Chicago, IL (2003); served sequentially as a research fellow in Memorial Sloan-Kettering Cancer Center, NY and research associate in Northwestern University; and joined VeroScience LLC in 2009 as a neuroscientist working on understanding brain dopaminergic system in the pathogenesis and treatment of metabolic diseases such as type II diabetes.
Donna Cowan, CCRC
Lead Project Manager
Ms. Cowan holds a degree in Health Care Administration from Stonehill College in Easton, MA and in 2005 qualified through the Association of Clinical Research Professionals as a Certified Clinical Research Coordinator.
Ms. Cowan acts as Project Manager for Medical Affairs and Clinical Research Operations.
